HKD 0.46
(-5.21%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 786.46 Million HKD | 15.24% |
2022 | 682.48 Million HKD | -14.08% |
2021 | 794.28 Million HKD | -10.17% |
2020 | 884.23 Million HKD | 3.29% |
2019 | 856.08 Million HKD | 12.14% |
2018 | 763.42 Million HKD | 35.89% |
2017 | 561.79 Million HKD | -33.23% |
2016 | 841.37 Million HKD | 80.76% |
2015 | 465.45 Million HKD | 11.76% |
2014 | 416.48 Million HKD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 768.84 Million HKD | 0.0% |
2023 Q4 | 786.46 Million HKD | 0.0% |
2023 Q3 | 786.46 Million HKD | 11.28% |
2023 Q1 | 706.75 Million HKD | 3.56% |
2023 Q2 | 706.75 Million HKD | 0.0% |
2023 FY | 786.46 Million HKD | 15.24% |
2022 Q4 | 682.48 Million HKD | 0.0% |
2022 Q1 | 824.25 Million HKD | 3.77% |
2022 Q3 | 682.48 Million HKD | -17.2% |
2022 Q2 | 824.25 Million HKD | 0.0% |
2022 FY | 682.48 Million HKD | -14.08% |
2021 Q4 | 794.28 Million HKD | 0.0% |
2021 Q1 | 802.74 Million HKD | -9.22% |
2021 Q2 | 802.74 Million HKD | 0.0% |
2021 FY | 794.28 Million HKD | -10.17% |
2021 Q3 | 794.28 Million HKD | -1.05% |
2020 Q3 | 884.23 Million HKD | 5.92% |
2020 Q4 | 884.23 Million HKD | 0.0% |
2020 FY | 884.23 Million HKD | 3.29% |
2020 Q1 | 834.78 Million HKD | -2.49% |
2020 Q2 | 834.78 Million HKD | 0.0% |
2019 Q2 | 863.38 Million HKD | 0.0% |
2019 FY | 856.08 Million HKD | 12.14% |
2019 Q4 | 856.08 Million HKD | 0.0% |
2019 Q3 | 856.08 Million HKD | -0.85% |
2019 Q1 | 863.38 Million HKD | 13.09% |
2018 Q4 | 763.42 Million HKD | 0.0% |
2018 Q2 | 692.96 Million HKD | 0.53% |
2018 FY | 763.42 Million HKD | 35.89% |
2018 Q1 | 689.3 Million HKD | 22.7% |
2018 Q3 | 763.42 Million HKD | 10.17% |
2017 Q2 | 863.01 Million HKD | 0.0% |
2017 Q1 | 863.01 Million HKD | 2.57% |
2017 Q3 | 558.04 Million HKD | -35.34% |
2017 Q4 | 561.79 Million HKD | 0.67% |
2017 FY | 561.79 Million HKD | -33.23% |
2016 FY | 841.37 Million HKD | 80.76% |
2016 Q4 | 841.37 Million HKD | 0.0% |
2016 Q1 | - HKD | 0.0% |
2016 Q3 | 841.37 Million HKD | 0.0% |
2015 FY | 465.45 Million HKD | 11.76% |
2014 FY | 416.48 Million HKD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -155.297% |
Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 26.056% |
China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -620.86% |
Prosperous Future Holdings Limited | 177.1 Million HKD | -344.058% |
Huasheng International Holding Limited | 675.58 Million HKD | -16.413% |
Fourace Industries Group Holdings Limited | 61.8 Million HKD | -1172.496% |
EC Healthcare | 2.97 Billion HKD | 73.522% |
Ming Fai International Holdings Limited | 772.01 Million HKD | -1.872% |
Blue Moon Group Holdings Limited | 1.61 Billion HKD | 51.388% |
SuperRobotics Holdings Limited | 172.27 Million HKD | -356.526% |
Takbo Group Holdings Limited | 42.84 Million HKD | -1735.436% |
Hyfusin Group Holdings Limited | 181.34 Million HKD | -333.678% |